DB
MRNA icon

Danske Bank’s Moderna MRNA Stock Holding History

Danske Bank’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$165K Hold
2,351
– – ﹤0.01% 659
2026
Q1 		$119K Sell
2,351
-3,734
-61% -$174K ﹤0.01% 674
2025
Q4 		$179K Hold
6,085
– – ﹤0.01% 684
2025
Q3 		$157K Hold
6,085
– – ﹤0.01% 808
2025
Q2 		$168K Sell
6,085
-120,714
-95% -$3.18M ﹤0.01% 799
2025
Q1 		$3.59M Sell
126,799
-18,200
-13% -$646K 0.01% 583
2024
Q4 		$6.03M Buy
144,999
+14,034
+11% +$671K 0.02% 502
2024
Q3 		$8.75M Sell
130,965
-1,192
-0.9% -$109K 0.03% 424
2024
Q2 		$15.7M Sell
132,157
-33,128
-20% -$4.19M 0.06% 277
2024
Q1 		$17.6M Buy
+165,285
New +$16.7M 0.06% 298

Other funds holding MRNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Danske Bank's MRNA Position: Q2 2026 in Review

Danske Bank held its Moderna (MRNA) position steady in Q2 2026 at 2,351 shares worth $165K. The position accounts for ﹤0.01% of the portfolio, ranked #659.

Danske Bank first reported a position in MRNA in Q1 2024 and has held it in 10 quarters since. The position peaked at $17.6M in Q1 2024. 629 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Danske Bank held 2,351 shares of Moderna worth $165K as of Q2 2026.
  • Danske Bank left its Moderna share count unchanged in Q2 2026.
  • Moderna made up ﹤0.01% of Danske Bank's portfolio in Q2 2026, its #659 holding.
  • Danske Bank first reported a position in Moderna in Q1 2024 and has held it in 10 quarters since.
  • Danske Bank's Moderna position peaked at $17.6M in Q1 2024.
  • 629 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.